Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLATIRAMER vs GLICLAZIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLATIRAMER vs GLICLAZIDE: Safety Overview

Metric GLATIRAMER GLICLAZIDE
Total FAERS Reports 46,357 5,784
Deaths Reported 696 483
Death Rate 1.5% 8.4%
Hospitalizations 5,831 3,195
Average Patient Age 48.4 yrs 65.0 yrs
% Female Patients 81.0% 55.2%
FDA Approval Date Apr 16, 2015 N/A
Manufacturer Zydus Pharmaceuticals USA Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Discontinued N/A